Pagamento aprovado... Acessos liberados

Seu pedido foi aprovado com sucesso

Já liberamos o acesso ao espaço exclusivo para assinantes.

Acessar área exclusiva

Pedido não processado :(

Infelizmente o seu pedido não foi processado pela operadora de cartão de crédito

Tente novamente clicando no botão abaixo

Voltar para o checkout

Busca

Buscar

Resultado de busca

101 resultados para a sua busca: Medicamento

Fundo do Mockup

Implications of resveratrol in obesity and insulin resistance: a state-of-t...

Implications of resveratrol in obesity and insulin resistance: a state-of-the-art review

Fundo do Mockup

Coverage for obesity prevention and treatment: analysis of state employee h...

Coverage for obesity prevention and treatment: analysis of state employee health plans and use of benefits

Fundo do Mockup

Weight loss and β‐cell responses following gastric banding or pharmacoth...

Weight loss and β‐cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial

Fundo do Mockup

Effects of liraglutide on gastrointestinal functions and weight in obesity:...

Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial

Fundo do Mockup

The effects of eight weeks’ very low-calorie ketogenic diet (VLCKD) on li...

The effects of eight weeks’ very low-calorie ketogenic diet (VLCKD) on liver health in subjects affected by overweight and obesity

Fundo do Mockup

Gordinhos ou obesos? A obesidade infantil sob uma perspectiva qualitativa e...

Gordinhos ou obesos? A obesidade infantil sob uma perspectiva qualitativa em um estudo com crianças e seus familiares

Fundo do Mockup

Medicines for obesity: appraisal of clinical studies with grading of recomm...

Medicines for obesity: appraisal of clinical studies with grading of recommendations, assessment, development, and evaluation tool

Fundo do Mockup

Glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and...

Glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptor poly-agonists: a new era in obesity pharmacotherapy

Fundo do Mockup

CD47 antisense oligonucleotide treatment attenuates obesity and its-associa...

CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction

Fundo do Mockup

Medicare part D coverage of antiobesity medications — challenges and unce...

Medicare part D coverage of antiobesity medications — challenges and uncertainty ahead